• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雾化吸入特布他林治疗哮喘:长期使用导致敏感性降低。

Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration.

作者信息

Weber R W, Smith J A, Nelson H S

出版信息

J Allergy Clin Immunol. 1982 Dec;70(6):417-22. doi: 10.1016/0091-6749(82)90003-3.

DOI:10.1016/0091-6749(82)90003-3
PMID:6815252
Abstract

The peak response and the duration of bronchodilator effect were measured after four inhalations at 20 min intervals of 250 micrograms of aerosolized terbutaline in 13 patients with bronchial asthma. Patients were initially studied after strict avoidance of all adrenergic agents for 2 wk; they were then studied at 2 wk intervals for 12 wk while receiving 500 micrograms of aerosolized terbutaline q.i.d. The initial testing (TI) and the testing at the end of 12 wk (TII) were double blind. Both peak response and duration of action decreased significantly between TI and TII. Cumulative dose-response curves showed that further improvement occurred after each inhalation during TI but that there was significant improvement only after the first inhalation during TII.

摘要

对13例支气管哮喘患者每隔20分钟吸入250微克雾化特布他林,共吸入4次后,测量支气管扩张剂效应的峰值反应和持续时间。患者最初在严格避免使用所有肾上腺素能药物2周后进行研究;然后在接受每日4次、每次500微克雾化特布他林治疗的同时,每隔2周进行12周的研究。初始测试(TI)和12周结束时的测试(TII)均为双盲。TI和TII之间的峰值反应和作用持续时间均显著降低。累积剂量-反应曲线显示,TI期间每次吸入后均有进一步改善,但TII期间仅在第一次吸入后有显著改善。

相似文献

1
Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration.雾化吸入特布他林治疗哮喘:长期使用导致敏感性降低。
J Allergy Clin Immunol. 1982 Dec;70(6):417-22. doi: 10.1016/0091-6749(82)90003-3.
2
Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.特布他林停药后气道梗阻和反应性的反弹:布地奈德的作用
Am J Respir Crit Care Med. 1996 Jan;153(1):70-5. doi: 10.1164/ajrccm.153.1.8542165.
3
Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients.低剂量硫酸特布他林雾化吸入对哮喘患者血流动力学、心脏及电解质的影响
Chest. 1998 Aug;114(2):380-7. doi: 10.1378/chest.114.2.380.
4
Selective subsensitization of beta-adrenergic receptors in central airways of asthmatics and normal subjects during long-term therapy with inhaled salbutamol.
J Allergy Clin Immunol. 1982 Dec;70(6):423-31. doi: 10.1016/0091-6749(82)90004-5.
5
Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.布地奈德/福莫特罗维持和缓解治疗经都保与固定剂量布地奈德/福莫特罗加特布他林治疗哮喘患者的疗效比较:III 期研究结果。
Respirology. 2013 Feb;18(2):354-63. doi: 10.1111/resp.12009.
6
Effects of treatment with formoterol on bronchoprotection against methacholine.福莫特罗治疗对乙酰甲胆碱支气管保护作用的影响。
Am J Med. 1998 May;104(5):431-8. doi: 10.1016/s0002-9343(98)00086-2.
7
Objective and subjective comparisons of terbutaline and rimiterol bronchodilator aerosols.特布他林和瑞米特罗支气管扩张气雾剂的客观与主观比较。
Br J Dis Chest. 1975 Oct;69(0):267-72. doi: 10.1016/0007-0971(75)90095-9.
8
Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.规律吸入β-受体激动剂治疗期间的支气管扩张剂耐受性和反跳性支气管收缩
Respir Med. 2000 Aug;94(8):767-71. doi: 10.1053/rmed.2000.0820.
9
Aerosolized terbutaline in asthmatics. Comparison of dosage strength, schedule, and method of administration.雾化吸入特布他林治疗哮喘患者。剂量强度、给药方案及给药方法的比较。
J Allergy Clin Immunol. 1979 Feb;63(2):116-21. doi: 10.1016/0091-6749(79)90201-x.
10
Effects of divided doses of a bronchodilator aerosol and the intervening time interval on the forced expiration.支气管扩张气雾剂的分次给药剂量及中间时间间隔对用力呼气的影响。
Respiration. 1986;50(1):49-56. doi: 10.1159/000194906.

引用本文的文献

1
Exercise-Induced Bronchoconstriction in Children: State of the Art from Diagnosis to Treatment.儿童运动诱发性支气管收缩:从诊断到治疗的最新进展
J Clin Med. 2024 Aug 5;13(15):4558. doi: 10.3390/jcm13154558.
2
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.福莫特罗和吸入皮质类固醇与沙美特罗和吸入皮质类固醇常规治疗慢性哮喘:严重不良事件。
Cochrane Database Syst Rev. 2021 Apr 14;4(4):CD007694. doi: 10.1002/14651858.CD007694.pub3.
3
Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.
用于哮喘治疗的吸入性类固醇联合或不联合常规沙美特罗:严重不良事件
Cochrane Database Syst Rev. 2018 Dec 3;12(12):CD006922. doi: 10.1002/14651858.CD006922.pub4.
4
Regular treatment with formoterol for chronic asthma: serious adverse events.福莫特罗用于慢性哮喘的常规治疗:严重不良事件
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD006923. doi: 10.1002/14651858.CD006923.pub3.
5
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.福莫特罗常规治疗与沙美特罗常规治疗慢性哮喘的严重不良事件
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD007695. doi: 10.1002/14651858.CD007695.pub3.
6
Regular treatment with salmeterol for chronic asthma: serious adverse events.沙美特罗用于慢性哮喘的常规治疗:严重不良事件
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD006363. doi: 10.1002/14651858.CD006363.pub2.
7
Recovery from bronchoconstriction and bronchodilator tolerance.支气管收缩的恢复与支气管扩张剂耐受性
Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):181-96. doi: 10.1385/CRIAI:31:2:181.
8
Clinical management of asthma in the 1990s. Current therapy and new directions.20世纪90年代哮喘的临床管理。当前的治疗方法与新方向。
Drugs. 1996;52 Suppl 6:1-11. doi: 10.2165/00003495-199600526-00003.
9
Causes and problems of nonresponse or poor response to drugs.药物无反应或反应不佳的原因及问题。
Drugs. 1996 Apr;51(4):552-70. doi: 10.2165/00003495-199651040-00004.
10
Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.哮喘中常规吸入β受体激动剂:对病情加重和肺功能的影响。
Thorax. 1993 Feb;48(2):134-8. doi: 10.1136/thx.48.2.134.